Bard gets clearance for colorectal stent

By AuntMinnie.com staff writers

April 26, 2000 --

C.R. Bard announced that it has received Food and Drug Administration 510(k) clearance for Memotherm, a colorectal stent for treating malignant obstructions resulting from colorectal cancer. Memotherm is a self-expanding nitinol stent that is preloaded on a flexible catheter and placed endoscopically in the colon, without the need for any incisions or general anesthesia, according to the Murray Hill, NJ-based firm. Bard's interventional products division will begin marketing Memotherm immediately.

By AuntMinnie.com staff writers
April 26, 2000
Copyright © 2000 AuntMinnie.com
 
Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: